Search results
Showing 4186 to 4200 of 8933 results
Clarification on demonstrating patient access to medicines and treatments recommended by NICE Technology Appraisal (TA) or Highly Specialised Technologies (HST) guidance.
Our forward view highlights the areas we will prioritise in the coming year.
Resources, case studies and patient decision aids to show how you can use evidence to improve care and services
Data on the recommendations made by our technology appraisal programme. Includes information on the number of positive recommendations we've made.
NICE makes 4 types of recommendation that allow us to produce clear, directive, actionable guidance that is easy to understand and put into practice.
Home What NICE does Our guidance Modular updates {"@context":"http://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem"
Over the next year, our prioritisation decisions will be shaped by the government’s strategic direction for health and life sciences, and by the needs of the NHS, local systems and the people who use services.
An approximate guide to the timings for the development of a piece of HealthTech guidance.
Our Medical Technologies Evaluation Programme (MTEP) evaluates new HealthTech.
We want you to be involved in our work - whether you’re commenting on our draft recommendations, taking part in guidance development or attending a committee meeting, your voice is important to us.
NICE has a key role in UK licensing and the evaluation of and access to new and innovative products for the health system.
Home What NICE does Our guidance About technology appraisal guidance {"@context":"http://schema.org","@type":"BreadcrumbList","itemListElement":
Data on the cancer recommendations made by our technology appraisal programme. Includes information on the number of positive recommendations we've made.
Technology appraisal submission templates and supporting documents
All the templates and supporting documents you need to make a technology appraisals submission with NICE.
Engage at the optimal time for your technology appraisal, to achieve NICE guidance at the same time as marketing authorisation.